Connect Biopharma Holdings Ltd
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation Cayman Islands
Business Address 3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO, CA, 92130
Mailing Address 3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO, CA, 92130
Phone 858-727-1040
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2025
-$15.63M
Net Income
$101.28M
Total Assets
$14.10M
Total Liabilities
$101.50M
Stockholders' Equity
$78.23M
Cash & Equivalents
$-0.28
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 16, 2026 | View on SEC |
| 3 Initial insider ownership report | March 16, 2026 | View on SEC |
| 3 Initial insider ownership report | March 16, 2026 | View on SEC |
| 3 Initial insider ownership report | March 16, 2026 | View on SEC |
| 3 Initial insider ownership report | March 16, 2026 | View on SEC |
| 3 Initial insider ownership report | March 16, 2026 | View on SEC |
Annual Reports
10-K March 31, 2026
- Focus on rademikibart (CBP-201) for inflammatory diseases like eczema and asthma.
- Strong cash position of $115.5 million to support ongoing clinical trials.
Related Companies
Companies in the same industry (SIC: 2834)
NERVGEN PHARMA CORP.
NGEN Pharmaceutical Preparations
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXT Pharmaceutical Preparations
TuHURA Biosciences, Inc./NV
HURA Pharmaceutical Preparations
Canton Strategic Holdings, Inc.
CNTN Pharmaceutical Preparations
BIOHARVEST SCIENCES INC.
BHST Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.